These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1887530)

  • 21. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Lancet; 1986 May; 1(8489):1056-8. PubMed ID: 2871335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers.
    Zhang J; Kumar S; Jayachandran M; Herrera Hernandez LP; Wang S; Wilson EM; Lieske JC
    BMC Nephrol; 2021 Jun; 22(1):204. PubMed ID: 34074247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of 24-hour urinary excretion of glycosaminoglycans by renal stone formers and healthy adults.
    Sidhu H; Hemal AK; Thind SK; Nath R; Vaidyanathan S
    Eur Urol; 1989; 16(1):45-7. PubMed ID: 2714317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the relation between citrate and calcium in normal and stone-former subjects.
    Conte A; Roca P; Gianotti M; Grases F
    Int Urol Nephrol; 1989; 21(4):369-73. PubMed ID: 2613466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in circadian rhythmicity in calcium oxalate renal stone formers.
    Touitou Y; Touitou C; Charransol G; Reinberg A; Thomas J; Bogdan A; Barthelemy C; Desgrez P
    Int J Chronobiol; 1983; 8(3):175-92. PubMed ID: 6862698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of citrate and urine on calcium oxalate crystal aggregation.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1993; 21(5):363-6. PubMed ID: 8279094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers.
    Prochaska ML; Moe OW; Asplin JR; Coe FL; Worcester EM
    Physiol Rep; 2021 Jul; 9(13):e14943. PubMed ID: 34231328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on crystalluria in calcium oxalate stone formers.
    Ahlstrand C; Tiselius HG; Larsson L
    Urol Res; 1984; 12(2):103-6. PubMed ID: 6539984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.